Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
10 pending office actions • 1 client • 9 examiners • 7 art units • 0 of 10 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
The Roquette Freres profile has 10 pending office actions in Biotechnology & Pharmaceuticals and is associated with 4,210 career applications. The reported resolved allowance rate is 58.39%, and the average is 4.43 office actions per allowance. Because the application and outcome figures match the broader firm profile, they provide portfolio context, while the pending-action figure identifies the current Roquette-related workload shown here.
The historical measures suggest that resolved cases may require sustained examination activity, but they do not predict the disposition of the 10 pending actions. A practitioner should separate client-specific docket management from the broader historical record when setting expectations. The action average can inform planning for amendments, arguments, and possible iterations, while the allowance rate provides a resolved-case benchmark. The data does not show which claim types or examination issues produced these results.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (50%) |
| Double-patenting + other | 1 (10%) |
| Multi-statute (no §101) | 4 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BERRY, LAYLA D | 2 | 66.0% | +9.0% |
| ZILBERING, ASSAF | 1 | 35.3% | +27.6% |
| LEE, SIN J | 1 | 68.8% | +25.1% |
| CRAIGO, WILLIAM A | 1 | 48.9% | +38.1% |
| TRAN, LIEN THUY | 1 | 28.7% | +26.5% |
| FAY, ZOHREH ALEMZADEH | 1 | 52.1% | -6.2% |
| PEEBLES, KATHERINE | 1 | 35.6% | +48.0% |
| YU, HONG | 1 | 31.1% | +5.7% |
| SCHACHERMEYER, SAMANTHA LYNN | 1 | 35.7% | +70.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18656260 | COMPOSITION COMPRISING GLUTEN-FREE FLOUR AND HYDROXYPROPYL METHYL CELLULOSE | TRAN, LIEN THUY | 86d overdue |
| 18292990 | CONTROLLED RELEASE COATING AGENT | FAY, ZOHREH ALEMZADEH | 62d |
| 18292993 | BIODEGRADABLE ALGINATE FILMS | PEEBLES, KATHERINE | 76d |
| 18877363 | FILM FORMING DELAYED/ENTERIC FORMULATIONS FOR HARD SHELL CAPSULES, FILMS AND COATINGS | LEE, SIN J | — |
| 18686630 | NOVEL HYDROXYALKYL METHYLCELLULOSE AND ITS USE | BERRY, LAYLA D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18656260 | COMPOSITION COMPRISING GLUTEN-FREE FLOUR AND HYDROXYPROPYL METHYL CELLULOSE | TRAN, LIEN THUY | 86d overdue |
| 18261296 | IMPROVED METHOD FOR THE PREPARATION OF MICROCRYSTALLINE CELLULOSE | SCHACHERMEYER, SAMANTHA LYNN | 31d overdue |
| 18292993 | BIODEGRADABLE ALGINATE FILMS | PEEBLES, KATHERINE | 76d |
| 19019080 | OLEOGEL WITH STEARIC ACID | ZILBERING, ASSAF | — |
| 18877363 | FILM FORMING DELAYED/ENTERIC FORMULATIONS FOR HARD SHELL CAPSULES, FILMS AND COATINGS | LEE, SIN J | — |
| 18897439 | SUSTAINED RELEASE COMPOSITION COMPRISING A HYDROXYALKYL METHYLCELLULOSE | CRAIGO, WILLIAM A | — |
| Client (Assignee) | Pending OAs |
|---|---|
| IFF | 10 |
| Art Unit | Apps |
|---|---|
| 1693 | 3 |
| 1617 | 2 |
| 1792 | 1 |
| 1613 | 1 |
| 1615 | 1 |
| 1793 | 1 |
| 1614 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19019080 | OLEOGEL WITH STEARIC ACID | Nutrition & Biosciences USA 1, LLC | ZILBERING, ASSAF | 1792 | §103 | Non-Final OA | — | Pending | Jan 13, 2025 |
| 18877363 | FILM FORMING DELAYED/ENTERIC FORMULATIONS FOR HARD SHELL CAPSULES, FILMS AND COATINGS | Nutrition & Biosciences USA 1, LLC | LEE, SIN J | 1613 | §102§103§112 | Non-Final OA | — | Pending | Dec 20, 2024 |
| 18897439 | SUSTAINED RELEASE COMPOSITION COMPRISING A HYDROXYALKYL METHYLCELLULOSE | Nutrition & Biosciences USA 1, LLC | CRAIGO, WILLIAM A | 1615 | §103§112DP | Non-Final OA | — | Pending | Sep 26, 2024 |
| 18656260 | COMPOSITION COMPRISING GLUTEN-FREE FLOUR AND HYDROXYPROPYL METHYL CELLULOSE | Nutrition & Biosciences USA 1, LLC | TRAN, LIEN THUY | 1793 | §103 | Final Rejection | 86d overdue | Pending | May 06, 2024 |
| 18686630 | NOVEL HYDROXYALKYL METHYLCELLULOSE AND ITS USE | Nutrition & Biosciences USA 1, LLC | BERRY, LAYLA D | 1693 | §102§103 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18292990 | CONTROLLED RELEASE COATING AGENT | Nutrition & Biosciences USA 1, LLC | FAY, ZOHREH ALEMZADEH | 1617 | §103§112 | Non-Final OA | 62d | Pending | Jan 29, 2024 |
| 18292993 | BIODEGRADABLE ALGINATE FILMS | Nutrition & Biosciences USA 1, LLC | PEEBLES, KATHERINE | 1617 | §102§103§112Other | Non-Final OA | 76d | Pending | Jan 29, 2024 |
| 18493184 | COMPOSITION CONTAINING CATIONIC HYDROXYETHYL CELLULOSE | Nutrition & Biosciences USA 1, LLC | YU, HONG | 1614 | §103 | Final Rejection | — | Pending | Oct 24, 2023 |
| 18261296 | IMPROVED METHOD FOR THE PREPARATION OF MICROCRYSTALLINE CELLULOSE | Nutrition & Biosciences USA 1, LLC | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §103 | Non-Final OA | 31d overdue | Pending | Jul 13, 2023 |
| 18261304 | IMPROVED METHOD FOR THE PREPARATION OF COLLOIDAL MICROCRYSTALLINE CELLULOSE | Nutrition & Biosciences USA 1, LLC | BERRY, LAYLA D | 1693 | §103 | Final Rejection | — | Pending | Jul 13, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial58.4% of resolved applications prosecuted by Arnold & Porter Kaye Scholer LLP - Roquette Freres were allowed, across 4,210 applications in USPTO records.
4.43 office actions per allowed application on average.
10 pending office actions as of October 2026, for 1 client, before 9 examiners in 7 art units.
